Explore
13D/13G Activist Filings
121,565 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | DK | Delek US Holdings, Inc | Ion Asset Management Ltd. | 13G | 5.0% | 3.3M |
| Nov 14, 2025 | OBIO | Orchestra BioMed Holdings, Inc. | Perceptive Advisors LLC | 13G/A | 10.0% | 5.7M |
| Nov 14, 2025 | TTAN | ServiceTitan, Inc. | ICONIQ Strategic Partners II, L.P. | 13G/A | 4.5% | 3.6M |
| Nov 14, 2025 | AMLX | Amylyx Pharmaceuticals, Inc. | Perceptive Advisors LLC | 13G/A | 8.2% | 9.0M |
| Nov 14, 2025 | IVA | Inventiva S.A. | Perceptive Advisors LLC | 13G/A | 5.0% | 7.3M |
| Nov 14, 2025 | UNIT | Uniti Group Inc. | Pacific Investment Management Company LLC | 13G | 10.7% | 25.5M |
| Nov 14, 2025 | NTSK | Netskope, Inc. | ICONIQ Strategic Partners II, L.P. | 13G | 16.8% | 13.2M |
| Nov 14, 2025 | FIG | Figma, Inc. | ICONIQ Strategic Partners VII, L.P. | 13G | 0.2% | 1.0M |
| Nov 14, 2025 | AORT | ARTIVION, INC. | Perceptive Advisors LLC | 13G/A | 4.3% | 2.0M |
| Nov 14, 2025 | FRTY | Alger Mid Cap 40 ETF, a series of The Alger ETF Trust | Alger Associates, Inc. | 13G/A | 5.2% | 285K |
| Nov 14, 2025 | FBRX | Forte Biosciences, Inc. | Alger Associates, Inc. | 13G/A | 13.1% | 1.6M |
| Nov 14, 2025 | HCMA | HCM III Acquisition Corp. | HCM Investor Holdings III, LLC | 13G | 25.0% | 8.4M |
| Nov 14, 2025 | ALDX | Aldeyra Therapeutics, Inc. | Perceptive Advisors LLC | 13G/A | 8.7% | 5.2M |
| Nov 14, 2025 | MESA | MESA AIR GROUP INC | PAR Investment Partners, L.P. | 13G/A | 6.2% | 2.6M |
| Nov 14, 2025 | TRAW | Traws Pharma, Inc. | Perceptive Advisors LLC | 13G/A | 10.0% | 887K |
| Nov 14, 2025 | KALA | KALA BIO, Inc. | Perceptive Advisors LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | VRNA | Verona Pharma plc | Perceptive Advisors LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | SSUP | Superior Industries International, Inc. | RIVA RIDGE CAPITAL MANAGEMENT LP | 13G | 4.2% | 1.6M |
| Nov 14, 2025 | PRLB | Proto Labs Inc | DISCIPLINED GROWTH INVESTORS INC /MN | 13G/A | 10.9% | 2.6M |
| Nov 14, 2025 | RAC | Rithm Acquisition Corp | First Trust Merger Arbitrage Fund | 13G/A | 4.2% | 996K |
| Nov 14, 2025 | N/A | Nuveen Churchill Private Capital Income Fund | Teachers Insurance and Annuity Association of America | 13G/A | 7.1% | 3.6M |
| Nov 14, 2025 | BEAG | Bold Eagle Acquisition Corp. | Centiva Capital, LP | 13G | 6.0% | 1.6M |
| Nov 14, 2025 | PCAPU | ProCap Acquisition Corp | Centiva Capital, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | PCAP | ProCap Acquisition Corp | Centiva Capital, LP | 13G | 5.6% | 1.4M |
| Nov 14, 2025 | GEOS | GEOSPACE TECHNOLOGIES CORP | DISCIPLINED GROWTH INVESTORS INC /MN | 13G/A | 9.0% | 1.2M |
| Nov 14, 2025 | OYSE | Oyster Enterprises II Acquisition Corp | Meteora Capital, LLC | 13G | 5.2% | 1.3M |
| Nov 14, 2025 | RRAC | Rigel Resource Acquisition Corp. | Centiva Capital, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | VYGR | Voyager Therapeutics, Inc. | EcoR1 Capital, LLC | 13G/A | 6.8% | 4.0M |
| Nov 14, 2025 | NGNE | Neurogene Inc. | EcoR1 Capital, LLC | 13G/A | 9.9% | 1.4M |
| Nov 14, 2025 | APLS | Apellis Pharmaceuticals, Inc. | EcoR1 Capital, LLC | 13G/A | 2.7% | 3.4M |
| Nov 14, 2025 | BOXL | Boxlight Corporation | Anson Funds Management LP | 13G | 6.0% | 333K |
| Nov 14, 2025 | CLB | Core Laboratories Inc. /DE/ | DISCIPLINED GROWTH INVESTORS INC /MN | 13G/A | 12.8% | 6.0M |
| Nov 14, 2025 | CNF | CNFinance Holdings Ltd. | Gagnon Securities LLC | 13G/A | 4.9% | 67.0M |
| Nov 14, 2025 | OAKU | Oak Woods Acquisition Corp | Meteora Capital, LLC | 13G/A | 8.5% | 303K |
| Nov 14, 2025 | XNET | Xunlei Ltd | Best Ventures Limited (previously known as Xiaomi Ventures Limited) | 13D/A | 42.7% | 133.0M |
| Nov 14, 2025 | NBR | Nabors Industries Ltd. | Varde Investment Partners (Offshore) Master, L.P. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | CCIA | Carlyle Credit Income Fund | Eagle Point Credit Management LLC | 13G/A | 15.7% | 330K |
| Nov 14, 2025 | ZURA | Zura Bio Ltd | Great Point Partners, LLC | 13G/A | 5.9% | 3.8M |
| Nov 14, 2025 | N/A | Orielle Acquisition Corp. | Ian Jacobs | 13G | 5.0% | 250K |
| Nov 14, 2025 | FCRS.U | FutureCrest Acquisition Corp. | Anson Funds Management LP | 13G | 9.8% | 2.5M |
| Nov 14, 2025 | N/A | Var Acquisition Corp. | Ian Jacobs | 13G | 25.0% | 2.5M |
| Nov 14, 2025 | ALRM | Alarm.com Holdings, Inc. | DISCIPLINED GROWTH INVESTORS INC /MN | 13G/A | 6.7% | 3.3M |
| Nov 14, 2025 | N/A | Los Altos Ventures Corp. | Ian Jacobs | 13G | 25.0% | 2.5M |
| Nov 14, 2025 | N/A | Var Acquisition Corp. | Mark N. Tompkins | 13G | 75.0% | 7.5M |
| Nov 14, 2025 | N/A | Orielle Acquisition Corp. | Mark N. Tompkins | 13G | 95.0% | 4.8M |
| Nov 14, 2025 | N/A | Los Altos Ventures Corp. | Mark N. Tompkins | 13G | 75.0% | 7.5M |
| Nov 14, 2025 | EVH | Evolent Health, Inc. | Eventide Asset Management, LLC | 13G/A | 5.4% | 6.3M |
| Nov 14, 2025 | N/A | Deep Isolation Nuclear, Inc. | Mark N. Tompkins | 13G/A | 4.0% | 2.3M |
| Nov 14, 2025 | N/A | Deep Fission, Inc. | Mark N. Tompkins | 13G/A | 5.8% | 3.0M |
| Nov 14, 2025 | ALMU | Aeluma, Inc. | Mark N. Tompkins | 13G/A | 16.0% | 2.9M |